CRNX · Crinetics Pharmaceuticals, Inc.
$83.90
+0.03 (+0.04%)
At close · Jul 21
Market Cap
$8.85B
Shares
105.44M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-06-21 | $350,000,000 | — | — | — | 10-Q , filed 2026-05-07 |
Key facts
CIK
1658247
CUSIP
22663K107
13F (30d)
24 filings
23 filers
Visit website
Investor relations